HPV相关口咽癌幸存者的癌症复发恐惧
该横断面研究纳入136例完成根治性(放化疗)至少12个月的HPV相关口咽癌幸存者,评估癌症复发恐惧(FCR)的患病率及相关特征。结果显示53%的患者存在临床水平FCR(FCRI-SF≥13),年轻、较低整体生活质量、较高症状干扰及焦虑抑郁负担与FCR升高显著相关。
要点
- 约53%的HPV相关口咽癌幸存者存在临床水平FCR(FCRI-SF≥13)。
- 年轻、低整体生活质量、高症状干扰及焦虑抑郁与FCR升高相关。
- 临床水平FCR患者中60%认为专业心理援助会有帮助,高于非临床水平的33%。
核心结论
- 约半数HPV相关口咽癌幸存者存在临床水平FCR,FCR升高与年轻、较低整体生活质量、较高症状干扰及焦虑抑郁负担相关。
研究设计与样本
- 横断面研究,纳入136例完成根治性放化疗至少12个月的HPV相关口咽癌幸存者,中位年龄61岁,84%男性,中位治疗距今年限2.8年。
主要发现
- 135例可评估患者中72例(53%;95%CI 45%-62%)存在临床水平FCR(FCRI-SF≥13)。
- FCR评分升高与年轻年龄(每5年-0.9;95%CI -1.7至-0.01;P=.031)相关。
- FCR评分升高与较低整体生活质量(每10单位增加-0.8;95%CI -1.4至-0.2;P=.012)相关。
- FCR评分升高与较高症状干扰(每单位0.8;95%CI 0.1-1.5;P=.017)相关。
- FCR评分升高与较高焦虑(每单位0.4;95%CI 0.3-0.5;P<.001)及抑郁(每单位0.3;95%CI 0.1-0.4;P<.001)负担相关。
关键数值与推荐
- 临床水平FCR定义为FCRI-SF评分≥13,135例中72例(53%;95%CI 45%-62%)达到该阈值。
- 临床水平FCR患者中60%认为专业心理援助会有帮助,非临床水平患者中为33%(P=.002)。
临床怎么用
- 对HPV相关口咽癌幸存者应常规评估FCR,尤其关注年轻、整体生活质量较低、症状干扰及焦虑抑郁负担较高的患者。
- 对存在临床水平FCR的患者可考虑提供专业心理援助。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To estimate the prevalence of and characteristics associated with fear of cancer recurrence (FCR) among human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) survivors. METHODS AND MATERIALS: We conducted a cross-sectional study in HPV-OPC survivors ≥12 months from completion of definitive (chemo)radiation therapy (RT/CRT). Eligible patients completed the Fear of Cancer Recurrence Inventory short-form (FCRI-SF), the European Organisation for research and Treatment of Cancer QLQ-C30, MD Anderson Symptom Inventory-Head and Neck, and PROMIS Anxiety and Depression short forms. Associations between FCRI-SF scores and other variables were investigated using linear regression models. RESULTS: A total of 136 HPV-OPC survivors were enrolled; the median age was 61 years (range, 42-87 years), 84% were male, 72% were currently partnered, 83% were current nonsmokers, 67% were regular alcohol consumers, and the median time since treatment was 2.8 years (range, 1.0-5.5 years). Clinical levels of FCR (≥13) were observed in 72 of 135 patients (53%; 95% confidence interval [CI], 45%-62%). Characteristics significantly associated with increasing FCR scores were younger age (-0.9/5 years; 95% CI, -1.7 to -0.01; P = .031), lower global quality of life (-0.8/10 unit increase; 95% CI, -1.4 to -0.2; P = .012), higher symptom interference (0.8/unit increase; 95% CI, 0.1-1.5; P = .017), and a higher burden of anxiety (0.4/unit; 95% CI, 0.3-0.5; P <.001) and depression (0.3/unit; 95% CI, 0.1-0.4; P <.001). Other sociodemographic tumor- and treatment-related characteristics were not statistically significant. Compared with patients reporting nonclinical levels of FCR, significantly more patients reporting clinical levels of FCR than expected believed professional psychological assistance would have been beneficial (60% vs 33%; P = .002). CONCLUSIONS: Clinical levels of FCR were observed in approximately half of the HPV-OPC survivors. Survivors reporting higher FCR were younger with worse self-reported global quality of life and higher symptom interference and emotional distress. No other patient, tumor, or treatment factors were associated with higher FCR.
引用
- Casswell G, Gough K, Drosdowsky A, et al. Fear of Cancer Recurrence in Survivors of Human Papillomavirus-Associated Oropharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2021. PMID: 34265396. doi:10.1016/j.ijrobp.2021.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。